Please use this identifier to cite or link to this item:
10.1159/000492210
Title: | Multimodality Treatment of a Colorectal Cancer Stage IV Patient with FOLFOX-4, Bevacizumab, Rigvir Oncolytic Virus, and Surgery |
Authors: | Tilgase, Andra Olmane, Evija Nazarovs, Jurijs Brokane, Linda Erdmanis, Romualds Rasa, Agnija Alberts, Peteris |
Keywords: | Angiogenesis inhibitor;Bevacizumab;Colorectal cancer;ECHO-7 virus;Multimodality treatment;Oncolytic virus;Rigvir;3.2 Clinical medicine;1.1. Scientific article indexed in Web of Science and/or Scopus database;Gastroenterology;SDG 3 - Good Health and Well-being |
Issue Date: | 1-May-2018 |
Citation: | Tilgase , A , Olmane , E , Nazarovs , J , Brokane , L , Erdmanis , R , Rasa , A & Alberts , P 2018 , ' Multimodality Treatment of a Colorectal Cancer Stage IV Patient with FOLFOX-4, Bevacizumab, Rigvir Oncolytic Virus, and Surgery ' , Case Reports in Gastroenterology , vol. 12 , no. 2 , pp. 457-465 . https://doi.org/10.1159/000492210 |
Abstract: | Colorectal cancer is one of the most commonly diagnosed cancers worldwide. The treatment consists of surgical resection, systemic chemotherapy, and new biological agents. One more recently emerging treatment option is oncolytic virotherapy. Although the use of the new treatment methods shows improved overall and progression-free survival, in general, even with the new treatments, mortality remains high and combinations of treatments should be sought to treat patients with colorectal cancer. Here we report a stage IV colorectal cancer patient who received multimodality treatment including bevacizumab, FOLFOX-4, surgery, and the oncolytic virus Rigvir. The patient shows complete pathological remission and remains stable 7.7 years after initial diagnosis. The possible benefits of combining Rigvir oncolytic virus and bevacizumab should be investigated since in vitro research suggests that anti-angiogenesis agents improve viral distribution by altering the microenvironment of the tumor. |
Description: | Publisher Copyright: © 2018 The Author(s). |
DOI: | 10.1159/000492210 |
ISSN: | 1662-0631 |
Appears in Collections: | Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure |
Files in This Item:
File | Size | Format | |
---|---|---|---|
Multimodality_Treatment.pdf | 1.26 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.